Two are better than one: noninvasive assessment of liver fibrosis in nonalcoholic fatty liver disease. (Q50946137)

25 March 2018

editorial

0 references

title

Two are better than one: noninvasive assessment of liver fibrosis in nonalcoholic fatty liver disease. (English)

1 reference

25 March 2018

metabolic dysfunction–associated steatotic liver disease

main subject

1 reference

Grace Lai-Hung Wong

1

1 reference

25 March 2018

Henry Lik-Yuen Chan

series ordinal

2

1 reference

25 March 2018

publication date

11 March 2015

1 reference

25 March 2018

number of pages

3

1 reference

inferred from page(s)

published in

Hepatology international

1 reference

25 March 2018

volume

9

1 reference

25 March 2018

page(s)

481-483

1 reference

25 March 2018

issue

4

1 reference

25 March 2018

https://scigraph.springernature.com/pub.10.1007/s12072-015-9625-1

exact match

0 references

cites work

Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.

1 reference

https://api.crossref.org/works/10.1007%2FS12072-015-9625-1

How should we manage patients with non-alcoholic fatty liver disease in 2007?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-015-9625-1

Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-015-9625-1

Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease--the role of transient elastography and plasma cytokeratin-18 fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-015-9625-1

Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-015-9625-1

Transient elastography: Kill two birds with one stone?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-015-9625-1

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-015-9625-1

Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-015-9625-1

A novel 2-step approach combining the NAFLD fibrosis score and liver stiffness measurement for predicting advanced fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-015-9625-1

Development of a non-invasive algorithm with transient elastography (Fibroscan) and serum test formula for advanced liver fibrosis in chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-015-9625-1

Non-invasive algorithm of enhanced liver fibrosis and liver stiffness measurement with transient elastography for advanced liver fibrosis in chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-015-9625-1

Use of non-invasive parameters of non-alcoholic steatohepatitis and liver fibrosis in daily practice--an exploratory case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-015-9625-1

Coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis B--a prospective cohort study with paired transient elastography examinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-015-9625-1

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-015-9625-1

Validation of the NAFLD fibrosis score in a Chinese population with low prevalence of advanced fibrosis.

21 January 2018

1 reference

12 December 2020

Association between anthropometric parameters and measurements of liver stiffness by transient elastography

1 reference

12 December 2020

Increased liver stiffness measurement by transient elastography in severe acute exacerbation of chronic hepatitis B

1 reference

12 December 2020

Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography

1 reference

12 December 2020

Non-invasive diagnosis of non-alcoholic steatohepatitis by combined serum biomarkers

1 reference

12 December 2020

Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years

1 reference

12 December 2020

Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease

1 reference

12 December 2020

Community-based lifestyle modification programme for non-alcoholic fatty liver disease: a randomized controlled trial

1 reference

12 December 2020

Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease

1 reference

12 December 2020

10.1007/S12072-015-9625-1

Identifiers

DOI

1 reference

25 March 2018

PubMed ID

25788206

1 reference

25 March 2018